Close Menu

NEW YORK (360Dx) – Shares of Chembio Diagnostics jumped this morning on news that the company had decided not to proceed with a previously announced public offering of up to $25 million of its common stock.

In morning trading, shares of the firm on the Nasdaq were up more than 13 percent at $8.70.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.